Nationwide Survey on Implementation of 2011 Nuclear Regulatory Commission Policy on Release of Patients After 131I Therapy for Thyroid Cancer-Reference-Cited by-同舟云学术

Nationwide Survey on Implementation of 2011 Nuclear Regulatory Commission Policy on Release of Patients After 131I Therapy for Thyroid Cancer

Published:2019-08-26 Issue:3 Volume:61 Page:397-404
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Wu Di,Gomes Lima Cristiane J.,Bloom Gary,Burman Kenneth D.,Wartofsky Leonard,Van Nostrand Douglas

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference15 articles.

1. Selected radiation safety aspects including transportation and lodging after outpatient 131I therapy for differentiated thyroid cancer;Gomes-Lima;Thyroid.,2017

2. NRC Regulatory Issue Summary 2011-01 NRC policy on release of iodine-131 therapy patients under 10 CFR 35.75 to locations other than private residences. US Nuclear Regulatory Commission website. https://www.nrc.gov/docs/ML1036/ML103620153.pdf. Published January 25, 2011. Accessed October 22, 2019.

3. Zanzonico PB . Release criteria and other radiation safety considerations for radionuclide therapy. In: Aktolun C Goldsmith SJ , eds. Nuclear Medicine Therapy. New York, NY: Springer; 2013:409–424.

4. A closer look at the latest NRC patient release guidance;Silberstein;J Nucl Med.,2008

5. Amdur RJ Snyder G Mazzaferri EL . Requirements for outpatient release following I-131 therapy. In: Amdur RJ Mazzaferri EL , eds. Essentials of Thyroid Cancer Management. New York, NY: Springer; 2005:177–182.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of the COVID-19 pandemic in nuclear medicine departments: preliminary report of the first international survey;European Journal of Nuclear Medicine and Molecular Imaging;2020-05-27